Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2019 | 1 |
2021 | 1 |
2022 | 2 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
The oral ferroportin inhibitor vamifeport improves hemodynamics in a mouse model of sickle cell disease.
Blood. 2022 Aug 18;140(7):769-781. doi: 10.1182/blood.2021014716.
Blood. 2022.
PMID: 35714304
Free PMC article.
Ferroportin inhibitor vamifeport ameliorates ineffective erythropoiesis in a mouse model of β-thalassemia with blood transfusions.
Kalleda N, Flace A, Altermatt P, Ingoglia G, Doucerain C, Nyffenegger N, Dürrenberger F, Manolova V.
Kalleda N, et al. Among authors: nyffenegger n.
Haematologica. 2023 Oct 1;108(10):2703-2714. doi: 10.3324/haematol.2022.282328.
Haematologica. 2023.
PMID: 37165842
Free PMC article.
Item in Clipboard
Tissue biodistribution of intravenous iron-carbohydrate nanomedicines differs between preparations with varying physicochemical characteristics in an anemic rat model.
Funk F, Weber K, Nyffenegger N, Fuchs JA, Barton A.
Funk F, et al. Among authors: nyffenegger n.
Eur J Pharm Biopharm. 2022 May;174:56-76. doi: 10.1016/j.ejpb.2022.03.006. Epub 2022 Mar 23.
Eur J Pharm Biopharm. 2022.
PMID: 35337966
Item in Clipboard
Oral ferroportin inhibitor ameliorates ineffective erythropoiesis in a model of β-thalassemia.
Manolova V, Nyffenegger N, Flace A, Altermatt P, Varol A, Doucerain C, Sundstrom H, Dürrenberger F.
Manolova V, et al. Among authors: nyffenegger n.
J Clin Invest. 2019 Dec 9;130(1):491-506. doi: 10.1172/JCI129382.
J Clin Invest. 2019.
PMID: 31638596
Free PMC article.
Item in Clipboard
The Oral Ferroportin Inhibitor VIT-2763 Improves Erythropoiesis without Interfering with Iron Chelation Therapy in a Mouse Model of β-Thalassemia.
Nyffenegger N, Flace A, Doucerain C, Dürrenberger F, Manolova V.
Nyffenegger N, et al.
Int J Mol Sci. 2021 Jan 16;22(2):873. doi: 10.3390/ijms22020873.
Int J Mol Sci. 2021.
PMID: 33467196
Free PMC article.
Item in Clipboard
Cite
Cite